Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... और पढ़ें
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with... और पढ़ें
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy ... और पढ़ें
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773194) titled 'Progressive Muscle Relaxation and Deep Breathing Exercises in Patients With COPD' on Aug. 1... और पढ़ें
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxe... और पढ़ें
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07771907) titled 'New Functional Ingredient for Oral Care' on June 22. Brief Summary: The goal of this clini... और पढ़ें
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773051) titled 'LineMatrix(R) Biological Vascular Graft for the Creation of Arteriovenous Graft' on Aug. 12... और पढ़ें
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Ad... और पढ़ें
U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774429) titled 'Evaluation of Psychophysical Responses After Mechanical Stimulation: a Reliability Study' o... और पढ़ें
Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant... और पढ़ें